These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Survival of heparins, oral anticoagulants, and aspirin after the year 2010. Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143 [TBL] [Abstract][Full Text] [Related]
5. Heparin and low molecular weight heparin in thrombosis and beyond. Mousa SA Curr Opin Investig Drugs; 2002 Aug; 3(8):1181-6. PubMed ID: 12211411 [TBL] [Abstract][Full Text] [Related]
6. Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged? Fareed J; Iqbal O; Cunanan J; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R Int Angiol; 2008 Jun; 27(3):176-92. PubMed ID: 18506123 [TBL] [Abstract][Full Text] [Related]
7. Management of deep vein thrombosis in cancer patients. Jahanzeb M J Natl Compr Canc Netw; 2005 Nov; 3 Suppl 1():S50-3. PubMed ID: 16280114 [No Abstract] [Full Text] [Related]
9. [Thrombosis in spite of warfarin--what should be done?]. Lassila R Duodecim; 2001; 117(24):2632-6. PubMed ID: 12183826 [No Abstract] [Full Text] [Related]
10. Subcutaneous low-molecular-weight heparin vs warfarin for prophylaxis of deep vein thrombosis after hip or knee implantation. An economic perspective. Hull RD; Raskob GE; Pineo GF; Feldstein W; Rosenbloom D; Gafni A; Green D; Feinglass J; Trowbridge AA; Elliott CG Arch Intern Med; 1997 Feb; 157(3):298-303. PubMed ID: 9040296 [TBL] [Abstract][Full Text] [Related]
11. Anticoagulant treatment of deep vein thrombosis and pulmonary embolism. Tran H; McRae S; Ginsberg J Cardiol Clin; 2008 May; 26(2):235-50, vi-vii. PubMed ID: 18406997 [TBL] [Abstract][Full Text] [Related]
12. Deep vein thrombosis and anticoagulant therapy. Sullano MA; Ortiz EJ Nurs Clin North Am; 2001 Dec; 36(4):645-63, v. PubMed ID: 11726345 [TBL] [Abstract][Full Text] [Related]
13. Anticoagulants in coronary artery disease. Lee LV Cardiol Clin; 2008 Nov; 26(4):615-28. PubMed ID: 18929235 [TBL] [Abstract][Full Text] [Related]
14. The venous side: current directions in anticoagulant therapy. Kaatz S J Am Osteopath Assoc; 2000 Nov; 100(11 Suppl):S17-21. PubMed ID: 11191117 [TBL] [Abstract][Full Text] [Related]
16. [Anticoagulant and antithrombotic effects of low molecular weight heparin]. Bashkov GV; Kalishevskaia TM; Bako N Biull Eksp Biol Med; 1988 Oct; 106(10):399-402. PubMed ID: 2847825 [TBL] [Abstract][Full Text] [Related]
17. Heparin, low molecular weight heparin, and derivatives in thrombosis, angiogenesis, and inflammation: emerging links. Mousa SA Semin Thromb Hemost; 2007 Jul; 33(5):524-33. PubMed ID: 17629850 [TBL] [Abstract][Full Text] [Related]
18. Initiation of warfarin therapy in elderly medical patients: a safe and accurate regimen. Arsura EL; Bobba RK Am J Med; 2005 Dec; 118(12):1449-50; author reply 1450. PubMed ID: 16378822 [No Abstract] [Full Text] [Related]